3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Testicular Germ Cell Tumor
1
Sarcoma
1
Pulmonary Disease, Chronic Obstructive
1
Ovarian Neoplasms
1
Neoplasms
1
Lung Diseases, Interstitial
1
Dyspnea
1
Breast Neoplasms
1
Interventions
pembrolizumab
16
Bevacizumab
11
Carboplatin
10
Nivolumab
8
Pemetrexed
7
Temozolomide
6
atezolizumab
5
Standard of Care
5
Prednisone
5
Exercise
5
Cyclophosphamide
5
Cetuximab
5
durvalumab
4
abemaciclib
4
Paclitaxel
4
Dexamethasone
4
Cisplatin
4
Blood Specimen Collection
4
dostarlimab
3
daratumumab
3
cabozantinib
3
Rituximab
3
Oxaliplatin
3
Metformin
3
Leucovorin
3
Lenalidomide
3
Ipilimumab
3
Fluorouracil
3
Doxorubicin
3
Docetaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Hypnosis
×
30 days
×
Clear all
NCT07173348
2026-06-04
HYPNEA
University Hospital, Geneva
Phase NA
Recruiting
82 enrolled